Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts

Area of Science:

• Pulmonology
• Infectious Diseases
• Microbiology

Background:

• Nontuberculous mycobacterial (NTM) infections originate from environmental mycobacteria.
• Pulmonary NTM disease frequently affects individuals with pre-existing lung conditions.
• Current diagnostic and treatment approaches for NTM infections are evolving and often empirical.

Purpose of the Study:

• To review current understanding and management strategies for progressive NTM lung disease.
• To discuss challenges in NTM treatment, including persistence and relapse.
• To identify areas for future research and development in NTM infection management.

Main Methods:

• Systematic review of peer-reviewed publications.
• Analysis of clinical guidelines and case series.
• Synthesis of data on diagnostic methods and treatment outcomes.

Main Results:

• Progressive NTM lung disease necessitates treatment, typically with multidrug regimens.
• Macrolide-based therapies are common, sometimes combined with surgical resection.
• Disease persistence and relapse are significant challenges, particularly with rapid-grower NTM.

Conclusions:

• Optimal treatment for NTM lung disease requires careful consideration of drug combinations, dosing, and patient selection for surgery.
• Further research is needed to improve epidemiology, identify risk factors, predict treatment outcomes, and develop new therapies.
• The management of NTM infections requires a multidisciplinary approach, balancing cure with observation or palliation when necessary.